000 | 01680 a2200445 4500 | ||
---|---|---|---|
005 | 20250514024906.0 | ||
264 | 0 | _c20020808 | |
008 | 200208s 0 0 eng d | ||
022 | _a0901-9928 | ||
024 | 7 |
_a10.1111/j.0901-9928.2001.890412.x _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLee, S H | |
245 | 0 | 0 |
_aTetrandrine prevents tissue inhibitor of metalloproteinase-1 messenger RNA expression in rat liver fibrosis. _h[electronic resource] |
260 |
_bPharmacology & toxicology _cOct 2001 |
||
300 |
_a214-6 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAlanine Transaminase _xblood |
650 | 0 | 4 |
_aAlkaline Phosphatase _xblood |
650 | 0 | 4 |
_aAlkaloids _xtherapeutic use |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAspartate Aminotransferases _xblood |
650 | 0 | 4 | _aBenzylisoquinolines |
650 | 0 | 4 |
_aCollagen Type I _xgenetics |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 |
_aDrugs, Chinese Herbal _xtherapeutic use |
650 | 0 | 4 |
_aHydroxyproline _xmetabolism |
650 | 0 | 4 |
_aImmunosuppressive Agents _xtherapeutic use |
650 | 0 | 4 |
_aLiver _xdrug effects |
650 | 0 | 4 |
_aLiver Cirrhosis, Experimental _xdrug therapy |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aRNA, Messenger _xmetabolism |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 | _aReverse Transcriptase Polymerase Chain Reaction |
650 | 0 | 4 |
_aTissue Inhibitor of Metalloproteinase-1 _xgenetics |
700 | 1 | _aNan, J X | |
700 | 1 | _aSohn, D H | |
773 | 0 |
_tPharmacology & toxicology _gvol. 89 _gno. 4 _gp. 214-6 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.0901-9928.2001.890412.x _zAvailable from publisher's website |
999 |
_c11788810 _d11788810 |